U.S. Hotel and Resort REITs Stock News

Why Immunovant is back on investors’ radar Immunovant (IMVT) has drawn fresh attention after completing enrollment in a potentially registrational IMVT-1402 trial for difficult rheumatoid arthritis, alongside a roughly US$550 million capital raise from institutional investors. See our latest analysis for Immunovant. At a share price of US$26.66, Immunovant has recently seen a 15.06% 90 day share price return and a 33.17% 1 year total shareholder return. This suggests momentum has built over...

If you are wondering whether NIKE's current share price reflects its true worth, you are not alone. The stock's long track record and strong brand often make investors ask what is actually a fair price. At the last close of US$57.01, NIKE's share price sits after a 7 day return of 8.3% decline, a 30 day return of 10.8% decline, a year to date return of 9.9% decline, and a 1 year return of 25.6% decline, alongside 3 year and 5 year returns of 48.6% and 56.2% declines respectively. Recent...

In the past quarter, West Pharmaceutical Services reported adjusted earnings per share of US$2.04 on revenue of US$805.00 million, raised its dividend, and authorized a share repurchase program alongside optimistic 2026 guidance tied to growing GLP-1 demand. This combination of earnings outperformance, confidence-backed capital returns, and GLP-1 exposure offers fresh context for assessing the company’s longer-term earnings power. We’ll now examine how West’s upbeat 2026 guidance, supported...

In early March 2026, Bath & Body Works reported fourth-quarter 2025 results showing lower sales of US$2,724 million and net income of US$403 million versus the prior year, and guided for 2026 net sales and earnings per share to decline, while also completing a share repurchase of 14,638,891 shares for US$382.85 million under its 2025 buyback plan. Management framed 2026 as a transition and investment year under its “Consumer First Formula,” refocusing on core fragrance and body care...

Why Slide Insurance Holdings is on investors’ radar Slide Insurance Holdings (SLDE) has drawn fresh attention after recent trading left the stock at US$18.48, with short term returns mixed and longer recent periods showing modest positive moves. For investors tracking insurers, Slide’s focus on coastal specialty homeowners and related property coverage, along with reinsurance and agency services, makes its latest price action a useful reference point when comparing peers and sector-specific...

Host Hotels & Resorts (HST) is back in focus after selling two resort properties for US$1.1b and outlining plans to recycle those proceeds into shareholder returns, acquisitions, and portfolio reinvestment. See our latest analysis for Host Hotels & Resorts. At a share price of US$19.23, Host Hotels & Resorts has seen short term share price pressure, with a 1 day return of 3.66% decline and a 7 day return of 1.84% decline. At the same time, a 90 day share price return of 12.46% and a 1 year...

Disc Medicine, Inc. reported full-year 2025 results showing a net loss of US$212.18 million, with basic loss per share from continuing operations of US$6.01, both higher than the prior year, and also filed a US$108.71 million common stock shelf registration related to its employee stock ownership plan. This combination of a larger annual loss and a sizeable ESOP-related shelf registration filing raises fresh questions about the company’s funding needs and capital structure priorities. With...

Recently, Smurfit Westrock raised recycled containerboard prices in Europe by €100 per metric ton, prompting expectations that peers such as International Paper could also benefit from a firmer pricing backdrop across the sector. This move underscores how pricing decisions by major European producers can ripple across global packaging markets, potentially influencing margin resilience and capacity discipline for International Paper. We’ll now examine how the prospect of wider containerboard...

Broadstone Net Lease (BNL) has been busy, adding two build-to-suit projects totaling about $62.1 million, closing a $350 million senior notes offering, and seeing its CFO increase his personal shareholding. See our latest analysis for Broadstone Net Lease. Those new build-to-suit commitments, the $350 million senior notes issuance and recent guidance sit against a 9.7% year to date share price return and a 20.8% 1 year total shareholder return, with shorter term momentum cooling slightly...

Autoliv, Inc. recently renewed its EUR 3,000 million guaranteed euro medium term note programme and appointed long‑time insider Monika Grama as Chief Financial Officer and Executive Vice President, Finance, effective April 1, 2026, succeeding outgoing CFO Fredrik Westin. The combination of refreshed funding flexibility through the EMTN programme and a new CFO with deep EMEA operational finance experience may influence how investors assess Autoliv’s financial policy and capital allocation...

Piper Sandler Companies recently expanded its healthcare investment banking franchise by appointing Jason Arnold as a managing director and naming Aamer Naseer global head of life sciences outsourcing and B2B medical technology, strengthening coverage across life science tools, diagnostics and medical devices. These hires deepen Piper Sandler’s sector expertise just as many investors are watching how specialized healthcare advisory capabilities could influence future fee opportunities and...

Pentair stock snapshot and recent performance Pentair (PNR) has been on many watchlists after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for Pentair. At a share price of $92.17, Pentair’s recent 1 day, 7 day and 90 day share price returns have been negative, while its 1 year and 3 year total shareholder returns remain positive, suggesting shorter term...

Knight-Swift Transportation Holdings (KNX) is back in focus after recent trading left the stock with mixed short term moves, including a 1-day decline and a negative month, alongside a positive past 3 months. See our latest analysis for Knight-Swift Transportation Holdings. At a share price of $56.87, Knight-Swift’s recent 1-day and 7-day share price declines sit against an 11.49% 3-month share price return and a 22.54% 1-year total shareholder return. This suggests longer term momentum has...

The recent US jobs report, which showed an unexpected decline in employment and roughly 30,000 restaurant and bar jobs lost, has pressured sentiment around Darden Restaurants (DRI) as investors reassess consumer discretionary spending. See our latest analysis for Darden Restaurants. The share price reaction to the weak jobs data comes after a 12.95% 90 day share price return that has now cooled, leaving Darden at US$203.18 with 7.51% 1 year total shareholder return and a much stronger 55.63%...

Zymeworks Inc. has released its fourth quarter and full-year 2025 results, reporting a net loss of US$41.21 million for the quarter and US$81.13 million for the year, alongside basic and diluted loss per share from continuing operations of US$0.55 for the quarter and US$1.08 for the year. On the same day, the company also filed a US$79.29 million shelf registration for 3,404,536 common shares under an ESOP-related offering, highlighting both ongoing capital needs and an increased emphasis on...

Apellis Pharmaceuticals, Inc. announced that Mikael Dolsten, M.D., Ph.D., former Pfizer chief scientific officer, joined its board of directors on March 1, 2026, adding decades of pharmaceutical R&D leadership to the company. Dolsten’s track record overseeing the regulatory approval of more than 36 medicines and vaccines may influence how investors assess Apellis’s ability to advance and commercialize its pipeline. Next, we’ll examine how Dolsten’s board appointment could interact with...

In recent months, PC Connection, Inc. reported flat year-on-year Q4 revenue that fell short of analyst expectations amid sector-wide hardware and supply chain headwinds. At the same time, the company raised its quarterly dividend and saw a sharp drop in short interest, developments that may signal improving confidence from both management and investors despite operational challenges. Next, we’ll examine how the dividend increase shapes PC Connection’s investment narrative around cash...

Why today’s sector jitters hit Walker & Dunlop Investor concern around private credit exposure, following Western Alliance Bancorporation’s loan write off, fed into fresh volatility for Walker & Dunlop (WD), even though the news is focused on sector risk rather than company specific developments. See our latest analysis for Walker & Dunlop. The 1 day share price return of 4.59% decline at a last close of $48.19 comes after a 7 day share price return of 4.74%, but a 30 day share price return...

In February 2026, Vaxcyte, Inc. reported a full-year 2025 net loss of US$766.63 million and completed a US$408.1 million follow-on equity offering, while also filing an additional US$500 million at-the-market program and a US$473.86 million shelf registration related to employee stock plans. These moves collectively highlight Vaxcyte’s reliance on equity financing to support its vaccine pipeline while absorbing widening losses, a pattern that can influence how investors assess funding risk...

In February 2026, Agilent Technologies reported first-quarter 2026 sales of US$1,798 million, with net income of US$305 million, and raised full-year 2026 revenue guidance to a range of US$7.30 billion to US$7.50 billion while issuing new second-quarter revenue guidance of US$1,790 million to US$1,820 million. Management’s decision to increase full-year revenue guidance while first-quarter earnings per share were slightly lower than a year earlier highlights confidence in cost control and...

Crown Castle (CCI) has been back in focus after fourth quarter 2025 results topped analyst estimates, followed by 2026 guidance and plans to sell its small cell and fiber businesses later this year. See our latest analysis for Crown Castle. The recent earnings beat, new 2026 guidance and the plan to sell the small cell and fiber businesses have coincided with an 11.81% 1-month share price return from Crown Castle, even though the 1-year total shareholder return of a 2.70% decline and 5-year...

Primerica stock reaction and recent performance snapshot Primerica (PRI) shares recently closed at US$257.31. The stock has seen mixed returns, with a 2.6% decline over the past day, a 6.7% decline over the past month, and a modest gain over the past 3 months. See our latest analysis for Primerica. While the 1-day share price return of 2.6% and 30-day share price return of 6.7% declines point to fading short term momentum, the 3-year total shareholder return of 59.38% and 5-year total...

In recent days, AGCO Corporation appointed former Corteva Agriscience CEO James C. Collins, Jr. to its Board of Directors, while also updating its annual incentive plan and highlighting significant expected 2026 tariff costs of about US$105 million to US$110 million at a major investor conference. This combination of governance changes, technology-focused initiatives, and tariff-related headwinds gives investors fresh information on how AGCO is balancing growth ambitions with cost and risk...

Humana (HUM) is in focus after pricing a US$1 billion junior subordinated notes offering due 2056. The notes received a stable credit rating from AM Best, drawing attention to the stock’s capital structure. See our latest analysis for Humana. Despite fresh headlines around the junior subordinated notes and new value based cardiac care partnerships, Humana’s 30 day share price return of 7.63% and year to date share price return of 32.26% highlight ongoing pressure. This is also reflected in a...